I am positive because of the diverse and fairly large pipeline. Tests are ongoing at major research centers. Read that paragraph I posted here earlier today on the vaccines that are being developed. If just one of those makes it, we are golden, IMO.
In addition, they have enough cash for about a year, and they are looking for more partners.
The reason the pps is so low and the interest so dead here is that the payoff is still a ways off. But this is a great price given the risk/reward profile.
But what do I know?
News 
Market Data 
Discover 
